Chronic sleep reduction in adolescents with Delayed Sleep Phase Disorder and effects of melatonin treatment

Sleep and Biological Rhythms

Volumn 11, Issue 2, 2013, Pages 99-104

  van Maanen, Annette ^a   Dewald Kaufmann, Julia F ^a,c   Smits, Marcel G ^b   Oort, Frans J ^a   Meijer, Anne Marie ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adolescents; Chronic sleep reduction; Delayed Sleep Phase Disorder; Melatonin

Indexed keywords

MELATONIN;

ADOLESCENCE; ADOLESCENT; ARTICLE; CHRONIC DISEASE; CHRONIC SLEEP REDUCTION QUESTIONNAIRE; CONTROLLED STUDY; DELAYED SLEEP PHASE DISORDER; DIM LIGHT MELATONIN ONSET; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; HUMAN; LIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP QUALITY;

EID: 84876299066     PISSN: 14469235     EISSN: 14798425     Source Type: Journal    
DOI: 10.1111/sbr.12010     Document Type: Article

References (19)

1. Borbély AA. A two process model of sleep regulation. Hum. Neurobiol. 1982; 1: 195-204.
2. Carskadon MA, Acebo C, Jenni OG. Regulation of adolescent sleep: implications for behavior. Ann. N. Y. Acad. Sci. 2004; 1021: 276-291.
3. Crowley SJ, Acebo C, Carskadon MA. Sleep, circadian rhythms, and delayed phase in adolescence. Sleep Med. 2007; 8: 602-612.
4. Meijer AM. Chronic sleep reduction, functioning at school and school achievement in preadolescents. J. Sleep Res. 2008; 17: 395-405.
5. Moore M, Meltzer LJ. The sleepy adolescent: causes and consequences of sleepiness in teens. Paediatr. Respir. Rev. 2008; 9: 114-121.
6. Rahman SA, Kayumov L, Tchmoutina EA, Shapiro CM. Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome. Sleep Med. 2009; 10: 549-555.
7. Wyatt JK, Stepanski EJ, Kirkby J. Circadian phase in Delayed Sleep Phase Syndrome: predictors and temporal stability across multiple assessments. Sleep 2006; 29: 1075-1080.
8. American Academy of Sleep Medicine. ICSD - International classification of sleep disorders, revised: Diagnostic and coding manual. American Academy of Sleep Medicine, 2001.
9. Sack RL, Auckley D, Auger R etal. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. Sleep 2007; 30: 1484-1501.
10. Van Geijlswijk IM, Korzilius HPLM, Smits MG. The use of exogenous melatonin in Delayed Sleep Phase Disorder: a meta-analysis. Sleep 2010; 33: 1605-1614.
11. Szeinberg A, Borodkin K, Dagan Y. Melatonin treatment in adolescents with Delayed Sleep Phase Syndrome. Clin. Pediatr. 2006; 45: 809-818.
12. Kayumov L, Brown G, Jindal R, Buttoo K, Shapiro CM. A randomized, double- blind, placebo-controlled crossover study of the effect of exogenous melatonin on Delayed Sleep Phase Syndrome. Psychosom. Med. 2001; 63: 40-48.
13. Van Maanen A, Meijer AM, Smits MG, Oort FJ. Melatonin and sleep effects on health, behavior problems and parenting stress. Sleep Biol. Rhythms 2011; 9: 165-171.
14. Van der Heijden KB, Smits MG, van Someren EJW, Gunning WB. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. J. Sleep Res. 2005; 14: 187-194.
15. Dewald JF, Short MA, Gradisar M, Oort FJ, Meijer AM. The Chronic Sleep Reduction Questionnaire (CSRQ): a cross-cultural comparison and validation in Dutch and Australian adolescents. J. Sleep Res. 2012; 21: 584-594.
16. Braam W, Van Geijlswijk I, Keijzer H etal. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J. Intellect. Disabil. Res. 2010; 54: 547-555.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences, Second edn. Erlbaum: Hillsdale, NJ, 1988.
18. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 1994; 271: 1609-1614.
19. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med. Rev. 2005; 9: 25-39.